SynthesisPediatric surgery international2025
Recent advances in pediatric colorectal cancer: a systematic review.
Synthesis in Pediatric surgery international, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Pediatric Colorectal Cancer in Africa: A Multicenter Study on Epidemiology, Management, and Outcomes Between 2000 and 2023.JGH open : an open access journal of gastroenterology and hepatology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeTo study the recent advances in Pediatric colorectal cancer (PCRC), including molecular profiling, clinical and genetic characteristics, screening guidelines, and treatment strategies.
methodA PubMed search was done on 25 March 2025, by using search words Pediatric colorectal cancer with a filter of last year, yielding 414 articles. On screening for relevant articles focusing on molecular profiles or screening guidelines in pediatric cases, 10 articles were selected, describing 38 tumors in 36 pediatric patients.
resultsClinical features of PCRC included unexplained abdominal pain, abdominal distension, vomiting, hematochezia, intestinal obstruction, and intestinal intussusception. Salient molecular profiling included distinct genomic landscapes in pediatric/ young adult CRC compared to adult CRC, and differences in WNT and PI3K-AKT pathways. PCRC had a significantly higher frequency of RNF43 mutations versus APC mutations in adults, suggesting age-related differences in WNT pathway activation. PCRC showed a peculiar profile with CDK6 amplification and enrichment of lysine degradation pathway. Few PCRC cases showed mismatch repair (MMR) deficiency, suggesting second-hit somatic alterations. The recent advances highlight in identifying hereditary cancer susceptibility syndromes and utility of indocyanine green fluorescence-guided surgery.
conclusionDistinct molecular signatures in PCRC underscore the need for age-specific treatment strategies, multidisciplinary care, and precision medicine to improve outcome for PCRC.
Indexed as
Identifiers
40531222What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.